Thea Cooper Barton, DO
Obstetrics & Gynecology · Blue Bell, PANPI 1881861920
Payments from drug & device makers
Across 238 payments — averaging $20.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Scynexis, Inc.$1K
- AbbVie$1K
- Therapeuticsmd, Inc.$529
- Mayne Pharma Commercial LLC$273
- Evofem Biosciences, Inc.$254
- Astellas Pharma US Inc$241
- plus $1K from 19 others
What the payments were for
- Consulting fees$1,00021%
- Food & beverage$3,78278%
- Education$531%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Scynexis, Inc. | 4 | $1,150 |
| AbbVie(2 entities) | 76 | $1,129 |
| Therapeuticsmd, Inc. | 37 | $529 |
| Mayne Pharma Commercial LLC | 20 | $273 |
| Evofem Biosciences, Inc. | 18 | $254 |
| Astellas Pharma US Inc | 8 | $241 |
| Avion Pharmaceuticals | 20 | $214 |
| Exeltis, USA Inc. | 11 | $193 |
| Coopersurgical, Inc. | 4 | $132 |
| Millicent US Inc | 4 | $99 |
| Lupin Inc. | 6 | $87 |
| Sumitomo Pharma America, Inc. | 5 | $75 |
| Mylan Pharmaceuticals Inc. | 4 | $71 |
| Sage Therapeutics, LLC | 2 | $66 |
| Currax Pharmaceuticals LLC | 4 | $62 |
| Hologic Sales And Service, LLC | 3 | $51 |
| Organon | 3 | $45 |
| Novo Nordisk | 2 | $30 |
| GSK | 1 | $23 |
| BD | 1 | $22 |
| Myovant Sciences Inc. | 1 | $22 |
| Avanos Medical | 1 | $20 |
| Pfizer | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
| Dysis Medical, Inc. | 1 | $16 |
How this compares
$4,835 in reported general payments places this provider in the 90th percentile of 1,711 obstetrics & gynecology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Spironolactone | 33 | $842 |
| Acyclovir | 11 | $427 |
| ValacyclovirValacyclovir Hcl | 12 | $310 |
| Metformin Hcl | 27 | $297 |
| Clindamycin Phosphate | 12 | $277 |
| Fluconazole | 37 | $202 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 11 | $160 |
| Hydrocortisone | 11 | $37 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Blue Bell
- Marvin KalaferJenkintown$4.6M
- Catherine ChappellPittsburgh$4.3M
- Stephen KlaskoPhiladelphia$2.2M
- Robert EdwardsPittsburgh$1.9M
- Stephanie SoberPhiladelphia$1.8M
- Michael ScutellaErie$1.7M
- Sarah TaylorPittsburgh$1.3M
- Andrea RoePhiladelphia$925K
- Beatrice ChenPittsburgh$549K
- Courtney SchreiberPhiladelphia$519K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.